SH
Samit Hirawat
Medical Oncology
Credentials: ·
Research
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
New England Journal of Medicine · 2019 · 2,067 citations
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
New England Journal of Medicine · 2016 · 1,581 citations
PTC124 targets genetic disorders caused by nonsense mutations
Nature · 2007 · 875 citations
- LM
6 papers
3 papers
- SA
3 papers
- DB
2 papers
2 papers
2 papers
- TA
2 papers
1 paper
